EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Management of Recurrent Venous Thromboembolism in Severe Immune Thrombocytopenia: A Case Report and a Review of the Literature

Mathias Haargaard Nielsen, Mustafa Vakur Bor

Hämostaseologie · 01.10.2024 · 44 (05) · 393-398

DOI: 10.1055/a-2159-8722 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hämostaseologie, erschienen am 01.10.2024. Verfasst von Mathias Haargaard Nielsen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Haematology Unit, Department of Internal Medicine, University Hospital of Southern Denmark, Esbjerg, Denmark. Hauptthemen laut MEDLINE: Venous Thromboembolism, Purpura, Thrombocytopenic, Idiopathic, Pyrazoles, Recurrence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a case of a 58-year-old man with recurrent unprovoked deep vein thrombosis (DVT) and severe immune thrombocytopenia (ITP) with a platelet count of 19 × 109/L. We further review studies reporting venous thromboembolism (VTE) in patients with severe ITP (≤ 35 × 109/L) and identified 14 patients highlighting VTE risk factors and management of these patients. The present case had several risk factors for VTE (previous DVT, obesity, heterozygosity for factor V Leiden mutation, and previous splenectomy). The patient was initially treated with low-molecular-weight heparin followed by long-term apixaban treatment. The literature review together with our case demonstrates that VTE in severe ITP (≤ 35 × 109/L) can occur in patients with VTE risk factors and antithrombotic management of these patients can be achieved without bleeding depending on severity of thrombocytopenia either by full or reduced dose of anticoagulation together with ITP therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismPurpura, Thrombocytopenic, IdiopathicPyrazolesRecurrenceHumansMaleMiddle AgedPyridonesHeparin, Low-Molecular-WeightAnticoagulantsRisk Factors

Substanzen

PyrazolesapixabanPyridonesHeparin, Low-Molecular-WeightAnticoagulants

Autor:innen und Institutionen

  • Haematology Unit, Department of Internal Medicine, University Hospital of Southern Denmark, Esbjerg, Denmark.
  • Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Esbjerg, Denmark.
  • Thrombosis and Anticoagulation Clinic, Department of Clinical Biochemistry, University Hospital of Southern Denmark, Esbjerg, Denmark.

Zitieren

APA

Nielsen, M. H., & Bor, M. V. (2024). Management of Recurrent Venous Thromboembolism in Severe Immune Thrombocytopenia: A Case Report and a Review of the Literature. Hämostaseologie, 44(05), 393-398. https://doi.org/10.1055/a-2159-8722

Vancouver

Nielsen MH, Bor MV. Management of Recurrent Venous Thromboembolism in Severe Immune Thrombocytopenia: A Case Report and a Review of the Literature. Hämostaseologie. 2024;44(05):393-398. doi:10.1055/a-2159-8722

BibTeX
@article{Nielsen2024,
  author = {Nielsen, Mathias Haargaard and Bor, Mustafa Vakur},
  title = {Management of Recurrent Venous Thromboembolism in Severe Immune Thrombocytopenia: A Case Report and a Review of the Literature},
  journal = {Hämostaseologie},
  year = {2024},
  volume = {44},
  number = {05},
  pages = {393--398},
  doi = {10.1055/a-2159-8722}
}
Kostenlos starten →